Literature DB >> 8381659

Production of interleukin 1 by rat pleural leucocytes in culture after intratracheal instillation of crocidolite asbestos.

X Y Li1, D Lamb, K Donaldson.   

Abstract

This study was undertaken to investigate the production of interleukin 1 (IL-1) by pleural leucocytes in culture and to evaluate the influence of intratracheal instillation of crocidolite asbestos on this production. Normal pleural leucocytes spontaneously released IL-1 in culture and stimulation with lipopolysaccharide (LPS) dramatically increased production. Intratracheal instillation with crocidolite asbestos induced recruitment of pleural leucocytes in the longer term and changed IL-1 production by the leucocytes. Reduced production of IL-1 was found by one day after instillation of asbestos and this was correlated with the dose of asbestos. With increasing time after instillation, however, release of IL-1 by pleural leucocytes gradually recovered to normal until, one month after asbestos injection, the leucocytes produced augmented IL-1 in culture compared with control pleural leucocytes. Our data show that pleural leucocytes possess the potential to produce IL-1 in vitro and this capability is altered by intratracheal instillation of crocidolite asbestos. This may be relevant to development of pleural diseases associated with inhalation of asbestos.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381659      PMCID: PMC1061240          DOI: 10.1136/oem.50.1.90

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  15 in total

Review 1.  Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.

Authors:  K Bendtzen
Journal:  Immunol Lett       Date:  1988-11       Impact factor: 3.685

2.  Mineral fibres and mesothelioma.

Authors:  J C Wagner; F D Pooley
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

Review 3.  Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.

Authors:  A Herbert
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

4.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

5.  Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes.

Authors:  T L Gerrard; J P Siegel; D R Dyer; K C Zoon
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

6.  Increased production of plasminogen activator inhibitor in vitro by pleural leukocytes from rats intratracheally instilled with crocidolite asbestos.

Authors:  X Y Li; G M Brown; D Lamb; K Donaldson
Journal:  Environ Res       Date:  1991-08       Impact factor: 6.498

7.  Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity.

Authors:  J A Elias; A D Schreiber; K Gustilo; P Chien; M D Rossman; P J Lammie; R P Daniele
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts.

Authors:  V M Kähäri; J Heino; E Vuorio
Journal:  Biochim Biophys Acta       Date:  1987-07-06

9.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.

Authors:  M D Wewers; S I Rennard; A J Hance; P B Bitterman; R G Crystal
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta.

Authors:  A E Postlethwaite; R Raghow; G P Stricklin; H Poppleton; J M Seyer; A H Kang
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

View more
  1 in total

1.  The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles.

Authors:  Ken Donaldson; Paul Ja Borm; Vincent Castranova; Mary Gulumian
Journal:  Part Fibre Toxicol       Date:  2009-04-27       Impact factor: 9.400

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.